AI in Healthcare and Digital Health Video Recap —December 17, 2025

LucidQuest

8 hours ago

Here’s your biweekly AI in Healthcare and Digital Health video brief covering key developments across digital health, AI regulation, and clinical innovation, spanning policy updates, real-world AI performance, and emerging signals shaping future healthcare delivery.

🎯 Watch Our Video Summary Capturing AI in Healthcare and Digital Health News from the Last Two Weeks

Dive deeper

🗓️ Explore more details and sources for the period 1– 14 December 2025

📚 Find your one-stop page for the full AI and Digital Health archive.

Transcript

Welcome to the latest edition of AI, Digital Health, and Regulation Updates, covering breakthroughs in the past two weeks. Brought to you by LucidQuest.

Experts in The BMJ warn that growing reliance on AI chatbots for companionship, especially among younger people, may worsen loneliness risks. They advise clinicians to gently screen for problematic chatbot use, particularly around the holidays, and to develop evidence-based strategies and safeguards.

The UK’s MHRA and Singapore’s HSA launched a joint regulatory innovation corridor. Developers can seek coordinated advice to design better trials and accelerate access to therapies in cancer, neurodegeneration, obesity, rare diseases, and advanced diagnostics. Flagship Pioneering will be the first participant.

An early-access npj Digital Medicine paper reports a smartphone-video deep learning model that assessed Parkinson’s gait. It achieved AUC 0.87 and F1 0.806, comparable to three specialists, detected medication-response signals, and surfaced interpretable digital biomarkers.

Investor Michael Burry defended his bearish AI-market views, predicting a “Netscape fate” for OpenAI and questioning Nvidia demand, while calling out reports of GPU warehousing. He argued the industry is primed for a very large IPO.

TechCrunch profiled Science Corp’s Prima retinal implant, a rice-grain chip for advanced macular degeneration used with camera glasses and a battery. In 38-patient trials, 80 percent could read again, two letters at a time. EU submission is in, with US timing uncertain and an initial cost near $200,000 per procedure.

Google introduced GenTabs, built with Gemini 3, an experiment that converts your tabs and chat context into interactive web apps and links outputs to sources. A macOS waitlist is open through the Disco program.

Microsoft’s Copilot Usage Report analyzed 37.5 million de-identified conversations. Health dominates mobile usage, advice-seeking is rising, coding peaks on weekdays while gaming trends on weekends, and late-night sessions skew to religion and philosophy.

The European Commission opened an antitrust probe into Google’s use of publisher content in AI Overviews and YouTube data practices. Concerns include inadequate compensation and opt-out controls. Penalties could reach 10 percent of global revenue if violations are found.

The WHO refreshed its Global Strategy on Digital Health 2020–2027, with plans to revise for 2028–2033. Priorities include knowledge-sharing, national digital strategies, robust governance on safety, privacy, interoperability, and people-centered systems, noting 129 countries with strategies and 1,600 officials trained.

Stay ahead in AI, Digital Health, and Regulation research! Like, share, and subscribe for our updates. Visit www.lqventures.com
or email us at info@lqventures.com for expert healthcare consulting. See you next time!

Why It matters

Regulators are experimenting with concurrent reviews to cut duplication and time to access in high-need areas.
Clinicians are being asked to recognize AI-related behaviors as part of mental health risk assessment.
Smartphone-native diagnostics and digital biomarkers could scale trial endpoints and home monitoring.
Usage data show AI moving from Q&A to advice, shaping product design and safety expectations.
Antitrust and content-use scrutiny will influence AI product features, data sourcing, and publisher economics.

🗓️ Explore more details and sources for the period 1– 14 December 2025

📚 Find your one-stop page for the full AI and Digital Health archive.

FAQ

What is the UK–Singapore “innovation corridor,” and who goes first?

A coordinated MHRA–HSA pathway for joint advice and faster development. Flagship Pioneering is first to access it [2].

How strong is the PD gait video model versus clinicians?

The npj Digital Medicine paper reports AUC 0.87 and F1 0.806, comparable to three specialists, with signals of medication responsiveness (early-access, may change) [3].

What exactly are BMJ authors asking clinicians to do about AI companions?

They recommend gentle inquiry about problematic chatbot use, escalating to targeted questions on compulsion, dependency, and attachment, especially around holidays [1].

What is GenTabs, and how do I try it?

A Google Labs experiment built with Gemini 3 that turns tab sets and context into small web apps, with a macOS waitlist via Disco [6].

What are the EU’s concerns with Google’s AI products?

Potential uncompensated use of publisher content for AI Overviews and YouTube training, with opt-out concerns; penalties could reach 10% of global revenue if violations are found [8].

What’s Science Corp’s near-term product and status?

“Prima,” a retinal implant plus glasses and battery, showed 80% of 38 patients able to read again (two letters at a time) in completed trials, with EU submission and uncertain US timing [5].

Entities / Keywords

Eli Lilly oral GLP-1 — not covered this week;
AI companionship, The BMJ, problematic chatbot use;
MHRA, HSA, innovation corridor, Flagship Pioneering;
Parkinson’s disease, UPDRS, digital biomarkers;
Michael Burry, OpenAI, Nvidia;
Science Corp, Prima, optogenetics, biohybrid neural interfaces;
Google, GenTabs, Gemini 3, Disco;
Microsoft Copilot, usage report, health advice;
European Commission, AI Overviews, YouTube;
WHO, digital health strategy, UHC.